← BMO 2025-5C10 Mortgage Trust · Loan annex · CMBS market
- Deal
- BMO 2025-5C10 Mortgage Trust
- Current balance
- $45.0M (September 2026)
- Share of deal
- 7.2%
- Status
- Current
- DSCR (latest)
- 2.83
- Occupancy (latest)
- 100%
- Scheduled maturity
- 2030-03-06
Property and terms
| Property | Muse at Torrey Pines |
| Address | 3040 and 3050 Science Park Road; San Diego, CA 92121 |
| Property type | Mixed use |
| Units, beds or keys | not yet reported |
| Net rentable square feet | 91,521 |
| Year built | 1985 |
| Year last renovated | 2021 |
| Original balance | $45.0M |
| Current balance | $45.0M (September 2026) |
| Share of deal balance | 7.2% |
| Interest rate at origination | 5.50% |
| Current interest rate | 5.50% |
| Origination date | 02-28-2025 |
| Original term | 60 months |
| Amortization term | not yet reported |
| Interest-only period | 60 months |
| Scheduled maturity | 2030-03-06 |
| Prepayment lockout end | 09-05-2029 |
| Yield maintenance end | not yet reported |
| Servicer | Midland Loan Services |
| Loan servicer | not yet reported |
| Originator | German American Capital Corporation |
| Current status | Current |
| Specially serviced now | No |
| Defeased | No |
Valuation
| Basis | Amount | Date | Source (as filed) |
|---|---|---|---|
| At securitization | $114.0M | 02-11-2025 | MAI |
| Most recent reported | $114.0M | 2025-02-11 | MAI |
Change from securitization to the most recent reported valuation: 0.0%.
Largest tenants
| Tenant | Square feet | Lease expiration |
|---|---|---|
| Prometheus Biosciences, Inc. | 27,834 | 04-30-2033 |
| Prometheus Biosciences, Inc, | 27,268 | 04-30-2033 |
| Organogenesis, Inc. | 22,966 | 06-30-2031 |
The three largest tenants as reported in the latest asset-level record.
Monthly history
| Month | Balance | Status | Rate | DSCR (NCF) | DSCR (NOI) | Occupancy | Advances | Financial period end | Revenue | Expenses | NOI | NCF |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 2025 | $45.0M | Current | 5.50% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| June 2025 | $45.0M | Current | 5.50% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| July 2025 | $45.0M | Current | 5.50% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| August 2025 | $45.0M | Current | 5.50% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| September 2025 | $45.0M | Current | 5.50% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| October 2025 | $45.0M | Current | 5.50% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| November 2025 | $45.0M | Current | 5.50% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| December 2025 | $45.0M | Current | 5.50% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| January 2026 | $45.0M | Current | 5.50% | 2.71 | 2.78 | 100% | $0 | 09-30-2025 | $10.9M | $3.9M | $7.0M | $6.8M |
| February 2026 | $45.0M | Current | 5.50% | 2.71 | 2.78 | 100% | $0 | 09-30-2025 | $10.9M | $3.9M | $7.0M | $6.8M |
| March 2026 | $45.0M | Current | 5.50% | 2.71 | 2.78 | 100% | $0 | 09-30-2025 | $10.9M | $3.9M | $7.0M | $6.8M |
| April 2026 | $45.0M | Current | 5.50% | 2.31 | 2.39 | 100% | $0 | 12-31-2025 | $9.8M | $3.8M | $6.0M | $5.8M |
| May 2026 | $45.0M | Current | 5.50% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| June 2026 | $45.0M | Current | 5.50% | not yet reported | not yet reported | not yet reported | $0 | not yet reported | not yet reported | not yet reported | not yet reported | not yet reported |
| July 2026 | $45.0M | Current | 5.50% | 2.83 | 2.91 | 100% | $0 | 03-31-2026 | $2.7M | $839,078 | $1.8M | $1.8M |
| August 2026 | $45.0M | Current | 5.50% | 2.83 | 2.91 | 100% | $0 | 03-31-2026 | $2.7M | $839,078 | $1.8M | $1.8M |
| September 2026 | $45.0M | Current | 5.50% | 2.83 | 2.91 | 100% | $0 | 03-31-2026 | $2.7M | $839,078 | $1.8M | $1.8M |
Revenue, expenses, net operating income (NOI) and net cash flow (NCF) are the most recent financials reported as of each month, for the financial period ending on the date shown. DSCR is debt service coverage on the net cash flow and net operating income bases as reported.
Sources: SEC Form ABS-EE asset-level reports for the deal. Definitions are in the methods note on the market page.